Position in MRK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$28,289,018
+$1,535,921 QoQ
Shares Held
220,148
-1.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.98%
of 13F equity value
Holder Rank
#433
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bryn Mawr Trust Advisors, LLC holds $73,679,493 across 10 Drug Manufacturers - General names. MRK ranks #1 (38.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
220,148 | $28,289,018 | |
| 2 | JNJ |
Johnson & Johnson
|
107,673 | $27,345,711 | |
| 3 | AZN |
Astrazeneca PLC
|
27,799 | $5,271,246 | |
| 4 | LLY |
ELI LILLY & Co
|
3,407 | $4,086,458 | |
| 5 | AMGN |
Amgen Inc
|
9,560 | $3,461,867 | |
| 6 | ABBV |
AbbVie Inc.
|
8,879 | $2,234,311 | |
| 7 | PFE |
Pfizer Inc
|
49,991 | $1,203,783 | |
| 8 | NVS |
Novartis AG
|
5,909 | $926,058 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,289,018 | 220,148 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $26,753,097 | 222,405 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $24,270,219 | 230,574 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $20,369,139 | 242,692 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $19,004,653 | 240,079 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $21,817,155 | 243,061 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $24,127,680 | 242,538 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $28,373,760 | 249,857 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $31,242,291 | 252,361 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $32,566,843 | 246,812 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $26,241,441 | 240,703 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $23,407,123 | 227,364 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $19,836,002 | 171,904 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $18,360,254 | 172,575 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $22,853,259 | 205,978 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,541,978 | 17,905 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,674,884 | 18,371 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,503,566 | 18,325 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,370,706 | 17,885 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,561,536 | 20,790 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,613,960 | 20,753 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,595,763 | 20,700 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,690,396 | 20,665 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,752,568 | 21,128 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,693,991 | 21,906 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,658,287 | 21,553 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||